Published date: 4 September 2020
Last edited date: 22 March 2022
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
United Kingdom, Isle of Man, Channel Islands
Value of contract
£214,000,000
Procurement reference
CM/PHS/20/5620/W
Published date
4 September 2020
Approach to market date
1 April 2022
Contract start date
1 July 2022
Contract end date
30 June 2024
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Haemophilia A
More information
Spend profile
Financial year | Budget |
---|---|
2022/2023 | £80,250,000 |
2023/2024 | £107,000,000 |
2024/2025 | £26,750,000 |
About the buyer
Contact name
Karen Bell
Address
Commercial Medicines Unit - NHS England
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
Approach to market date: 1 April 2022